- Home
- CRVS vs AII Comparison
CRVS vs AII Comparison
Compare CRVS & AII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- AII
- Stock Information
- Founded
- CRVS 2014
- AII 2006
- Country
- CRVS United States
- AII United States
- Employees
- CRVS N/A
- AII N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- AII Property-Casualty Insurers
- Sector
- CRVS Health Care
- AII Finance
- Exchange
- CRVS Nasdaq
- AII Nasdaq
- Market Cap
- CRVS 305.4M
- AII 370.5M
- IPO Year
- CRVS 2016
- AII 2025
- Fundamental
- Price
- CRVS $5.75
- AII $19.96
- Analyst Decision
- CRVS Strong Buy
- AII Buy
- Analyst Count
- CRVS 4
- AII 4
- Target Price
- CRVS $15.00
- AII $21.67
- AVG Volume (30 Days)
- CRVS 518.7K
- AII 78.8K
- Earning Date
- CRVS 08-07-2025
- AII 08-12-2025
- Dividend Yield
- CRVS N/A
- AII N/A
- EPS Growth
- CRVS N/A
- AII N/A
- EPS
- CRVS N/A
- AII 60.71
- Revenue
- CRVS N/A
- AII $260,047,000.00
- Revenue This Year
- CRVS N/A
- AII $25.82
- Revenue Next Year
- CRVS N/A
- AII $25.78
- P/E Ratio
- CRVS N/A
- AII $0.33
- Revenue Growth
- CRVS N/A
- AII 1.73
- 52 Week Low
- CRVS $2.54
- AII $15.78
- 52 Week High
- CRVS $10.00
- AII $20.32
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- AII N/A
- Support Level
- CRVS $5.28
- AII N/A
- Resistance Level
- CRVS $5.64
- AII N/A
- Average True Range (ATR)
- CRVS 0.30
- AII 0.00
- MACD
- CRVS 0.03
- AII 0.00
- Stochastic Oscillator
- CRVS 77.70
- AII 0.00
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About AII American Integrity Insurance Group Inc. Common Stock
American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.